Periprocedural myocardial infarction in stent trials: how universal is the third universal definition?

Rafael Cavalcante; Patrick W. Serruys

doi:10.4244/eijv12i7a133

Related publications

Letter2021

Have We Overdefined Periprocedural Myocardial Infarction to the Point of Extinction?

Patrick W. Serruys, Hironori Hara, Scot Garg, Yoshinobu Onuma

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Letter2020

Considerations for an optimal definition of procedural myocardial infarction

Gregg W. Stone, Ori Ben‐Yehuda, Joseph F. Sabik, A. Pieter Kappetein, Patrick W. Serruys

European Heart Journal

Article2023

Does Cardiac Troponin I Overestimate Periprocedural Myocardial Infarction When Compared to Cardiac Troponin T?

Pruthvi Chenniganahosahalli Revaiah, Gregg W. Stone, Shinichiro Masuda, Kai Ninomiya, Nozomi Kotoku, Shigetaka Kageyama, Yoshinobu Onuma, Patrick W. Serruys

Cardiovascular revascularization medicine

Article2018

IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS

Hector M. Garcia Garcia, Eugène McFadden, Clemens von Birgelen, Tessa Rademaker‐Havinga, Neal S. Kleiman, David J. Cohen, Kevin F. Kennedy, Edoardo Camenzind, Laura Mauri, Philippe Steg, William Wijns, Sigmund Silber, Gerrit‐Anne van Es, Patrick W. Serruys, Stephan Windecker, Donald E. Cutlip, Pascal Vranckx

Journal of the American College of Cardiology

Article2017

TCT-79 What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

Shmuel Chen, Ori Ben‐Yehuda, Thomas McAndrew, Ioanna Kosmidou, Björn Redfors, Marie‐Claude Morice, David E. Kandzari, Adrian Banning, Ovidiu Dressler, Martin B. Leon, A. Pieter Kappetein, Joseph F. Sabik, Patrick W. Serruys, Gregg W. Stone